Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Treasury Shares (2020)

Summit Therapeutics' Treasury Shares history spans 1 years, with the latest figure at $26923.0 for Q4 2020.

  • For Q4 2020, Treasury Shares changed N/A year-over-year to $26923.0; the TTM value through Dec 2020 reached $26923.0, changed N/A, while the annual FY2020 figure was $26923.0, N/A changed from the prior year.
  • Treasury Shares reached $26923.0 in Q4 2020 per SMMT's latest filing.
  • In the past five years, Treasury Shares ranged from a high of $26923.0 in Q4 2020 to a low of $26923.0 in Q4 2020.